BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25286028)

  • 1. Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer.
    Li Z; Wang Y; Yuan C; Zhu Y; Qiu J; Zhang W; Qi B; Wu H; Ye J; Jiang H; Yang J; Cheng J
    Lab Invest; 2014 Dec; 94(12):1431-45. PubMed ID: 25286028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.
    Li Z; Wang Y; Qiu J; Li Q; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Yang J; Cheng J
    Oncotarget; 2013 Dec; 4(12):2532-49. PubMed ID: 24345883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1.
    Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J
    Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    M JR; S V
    Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
    Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
    PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.
    Cho JH; Dimri M; Dimri GP
    J Biol Chem; 2015 Apr; 290(16):10555-67. PubMed ID: 25737447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.
    He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A
    Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
    Xu R; Chen L; Yang WT
    Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma.
    Wang Q; Li Z; Wu Y; Huang R; Zhu Y; Zhang W; Wang Y; Cheng J
    Cancer Cell Int; 2017; 17():107. PubMed ID: 29200967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer.
    Wei XL; Dou XW; Bai JW; Luo XR; Qiu SQ; Xi DD; Huang WH; Du CW; Man K; Zhang GJ
    Oncotarget; 2015 Aug; 6(25):21704-17. PubMed ID: 26023734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
    PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
    Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B
    Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability.
    Shen Z; Liao X; Shao Z; Feng M; Yuan J; Wang S; Gan S; Ha Y; He Z; Jie W
    BMC Cancer; 2019 Mar; 19(1):262. PubMed ID: 30902084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.